Exploring synergy between azole antifungal drugs and statins for Candida auris
Journal of Antimicrobial Chemotherapy · 2023
DOI: 10.1093/jac/dkad303 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Antimicrobial Chemotherapy, 2023. Verfasst von Catriona Halliday und 4 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Infectious Diseases and Microbiology Laboratory Services, Institute of Clinical Pathology and Medical Research, New South Wales Health Pat…. Hauptthemen laut MEDLINE: Antifungal Agents, Hydroxymethylglutaryl-CoA Reductase Inhibitors. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: The University of Sydney Infectious Diseases Institute.
Abstract (Originalsprache)
Background
Global emergence of rapidly developing resistance to multiple antifungal drugs and high mortality pose challenges to the treatment of invasive Candida auris infections. New therapeutic approaches are needed, such as repurposing drugs including combination with antifungals. Statins have been reported to exert antifungal effects against various Candida species.
Objectives
Our study investigated potential synergy between the statins (rosuvastatin and fluvastatin) and azoles (voriconazole, posaconazole and isavuconazole) on clinical isolates of C. auris.
Methods
Twenty-one clinical isolates of C. auris were obtained. Chequerboard assays based on the CLSI broth microdilution method were used to assess synergy based on FIC index (FICI) calculations of MICs of individual drugs and in combinations.
Results
Single drug geometric mean (GM) MICs of fluvastatin and rosuvastatin were ≥128 mg/L in all 21 isolates. GM (range) MICs of posaconazole, voriconazole and isavuconazole were 0.259 (0.016–1 mg/L), 0.469 (0.016–2 mg/L) and 0.085 (0.004–1 mg/L), respectively. Combination of azoles with fluvastatin showed synergy in 70%–90% of C. auris isolates. In particular, voriconazole/fluvastatin resulted in 16-fold reduction in voriconazole MIC and synergy in 14/21 (67%) isolates. Posaconazole/fluvastatin resulted in 8-fold reduction in posaconazole MIC and synergy in 19/21 (90%) isolates. Combining rosuvastatin with the azoles also showed synergy against C. auris in 40%–60% of the isolates and additive effect in 40%–50%. None of the combinations was antagonistic.
Conclusions
Our results provide a rationale for pursuing in vivo synergy tests as well as clinical studies to explore tolerability, treatment outcomes, optimal dose and exposure targets.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Centre for Infectious Diseases and Microbiology Laboratory Services, Institute of Clinical Pathology and Medical Research, New South Wales Health Pathology, Westmead Hospital, Westmead, NSW, Australia.
- Sydney Pharmacy School, Faculty of Medicine and Health, The University of Sydney, A15 Science Rd, Camperdown, NSW 2006, Australia.
- Department of Pharmacy, Westmead Hospital, Westmead, NSW, Australia.
- The University of Sydney Infectious Diseases Institute (Sydney ID), Westmead, NSW, Australia.
- Research Education Network, Western Sydney Local Health District, Westmead Hospital, Westmead, NSW, Australia.
- Sydney Medical School, Faculty of Medicine and Health, The University of Sydney, Camperdown, NSW, Australia.
ORCID-Profile: Hannah Yejin Kim, Jan-Willem Alffenaar
Förderung
- The University of Sydney Infectious Diseases Institute
Zitieren
APA
Halliday, C., Kim, H. Y., Tay, E., Chen, S. C. A., & Alffenaar, J. W. (2023). Exploring synergy between azole antifungal drugs and statins for Candida auris. Journal of Antimicrobial Chemotherapy. https://doi.org/10.1093/jac/dkad303
Vancouver
Halliday C, Kim HY, Tay E, Chen SCA, Alffenaar JW. Exploring synergy between azole antifungal drugs and statins for Candida auris. Journal of Antimicrobial Chemotherapy. 2023. doi:10.1093/jac/dkad303
BibTeX
@article{Halliday2023,
author = {Halliday, Catriona and Kim, Hannah Yejin and Tay, Enoch and Chen, Sharon C A and Alffenaar, Jan-Willem},
title = {Exploring synergy between azole antifungal drugs and statins for Candida auris},
journal = {Journal of Antimicrobial Chemotherapy},
year = {2023},
doi = {10.1093/jac/dkad303}
}
EUVIMED